Funding

 

Active Funding:

• NIH NHLBI, Grant 1 R01 HL130099

       2016 - 2020

       Project Title: Eicosapentaenoic acid prevents cardiac fibrosis via activation of free fatty acid receptor 4 in a mouse model        of hypertensive heart disease; implications for heart failure preserved ejection fraction.

​

• Amarin Pharmaceuticals

      EPA Mediated Cardioprotection​

      Project Title: EPA mediated cardioprotection

​

​

Completed Funding:

• American Heart Association GIA

      2015 - 2017

      Project Title: Free fatty acid receptor 4 is required for prevention of cardiac fibrosis by eicosapentaenoic acid

​​​

• NIH NCRR, Grant 2P20 RR017662-061A

      2008 - 2013​

      Project Title: alpha-1 adrenergic receptors prevent pathologic remodeling

      Role: Principle Investigator Project 1

      Parent COBRE Grant Title: Mechanisms of Cardiovascular Remodeling

​

• NIH NCRR, Grant 2P20 RR017662-061A

      2008 - 2013​

      Project Title: Cell Culture Core

      Role: Principle Investigator Cell Culture Core

      Parent COBRE Grant Title: Mechanisms of Cardiovascular Remodeling

​

• American Heart Association Scientist Development Grant 0435338Z

      2006 - 2008​

      Project Title: alpha1-Adrenergic receptor prevention of heart failure by inhibition of cardiac myocyte apoptosis.

​

• South Dakota 2010 Grant

      2004 - 2009​

      Project Title: Interactions between alpha1 and beta-adrenergic receptors and the implications of heart failure

      Parent SD 2010 Title: Signal Transduction Center

​